Results 21 to 30 of about 252,911 (302)

Intravenous infusion of prostaglandin E1 therapy in extremity ischemia

Indian Journal of Vascular and Endovascular Surgery, 2017
Prostaglandins are potent vasoactive agents with wide variety of other actions - vasodilatation, fibrinolysis and inhibition of platelet aggregation. PGE1 was the agent used since 1973 for cardiovascular diseases, mainly in patients with advanced PVD ...
Pinjala Ramakrishna
doaj   +1 more source

Genotype–phenotype correlation in two Polish neonates with alveolar capillary dysplasia

BMC Pediatrics, 2020
Background Alveolar capillary dysplasia (ACD) is a rare cause of severe pulmonary hypertension and respiratory failure in neonates. The onset of ACD is usually preceded by a short asymptomatic period.
Zuzanna Kozłowska, Zuzanna Owsiańska, Joanna P. Wroblewska, Apolonia Kałużna, Andrzej Marszałek, Yogen Singh, Bartłomiej Mroziński, Qian Liu, Justyna A. Karolak, Paweł Stankiewicz, Gail Deutsch, Marta Szymankiewicz-Bręborowicz, Tomasz Szczapa   +12 more
doaj   +1 more source

Prostaglandin E1 administration for prevention of contrast-induced acute kidney injury: A systematic review and meta-analysis of randomized controlled trials. [PDF]

Medicine (Baltimore), 2018
Geng N, Zou D, Chen Y, Ren L, Xu L, Pang W, Sun Y.   +6 more
europepmc   +2 more sources

Efeitos da prostaglandina E1 (PGE1) na gênese de capilares sanguíneos em músculo esquelético isquêmico de ratos: estudo histológico Effects of prostaglandin E1 (PGE1) in the genesis of blood capillaries in rat ischemic skeletal muscle: histological study

Jornal Vascular Brasileiro, 2007
CONTEXTO: A angiogênese terapêutica é uma modalidade de tratamento para pacientes com insuficiência arterial crônica que não têm indicação para revascularização direta ou angioplastia e que não tiveram uma resposta satisfatória ao tratamento clínico ...
Dorival Moreschi Jr., Djalma José Fagundes, Luiz Eduardo Bersani Amado, Luzmarina Hernandes, Hugo Karling Moreschi   +4 more
doaj   +1 more source

Prostaglandin E1 Analog: Comparison between Two Different Routes of Administration for the Prevention of Post-Partum Hemorrhage [PDF]

International Journal of Medical Arts, 2022
Background: Postpartum hemorrhage [PPH] is considered as the major cause of maternal death worldwide. A Prostaglandin E1 analog, Misoprostol, has been demonstrated to be useful in lowering intra and postoperative blood loss. However, the proper timing of
Moatazza Elghazaly
doaj   +1 more source

Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca Sildenafil for pulmonary hypertension treatment after cardiac surgery

Jornal de Pediatria, 2005
OBJETIVO: Relatar o uso do Sildenafil no tratamento da hipertensão pulmonar em recém-nascido após cirurgia cardíaca. DESCRIÇÃO: Recém-nascido de termo, feminino, com diagnóstico de dupla via de saída de ventrículo direito, hipoplasia de pulmonar e ...
Maria Regina Bentlin, Adriana Saito, Ana Karina C. De Luca, Grasiela Bossolan, Rossano C. Bonatto, Antonio S. Martins, Ligia M. S. S. Rugolo   +6 more
doaj   +1 more source

Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials. [PDF]

, 2014
BackgroundInhaled nitric oxide (INO), a selective pulmonary vasodilator, has revolutionized the treatment of neonatal hypoxemic respiratory failure (NHRF). However, there is lack of sustained improvement in 30 to 46% of infants.
Ambalavanan, Namasivayam, Bara, Rebecca, Cotten, C Michael, Das, Abhik, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, Garg, Meena, Higgins, Rosemary D, Keszler, Martin, Klein, Jonathan M, Lakshminrusimha, Satyan, Malian, Monica, Nelin, Leif D, Ohls, Robin, Saha, Shampa, Sanchez, Pablo J, Shankaran, Seetha, Sood, Beena G, Van Meurs, Krisa P, Wallace, Dennis   +18 more
core   +2 more sources

Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis

Upsala Journal of Medical Sciences, 2013
Prostaglandin E1 (alprostadil) is widely used for maintaining the patency of ductus arteriosus in ductus-dependent congenital heart defects in neonates to improve oxygenation. Among more common side effects are fever, rash, apnoea, diarrhoea, jitteriness,
T. Perme, S. Mali, I. Vidmar, Diana Gvardijančič, R. Blumauer, D. Mishaly, I. Grabnar, G. Nemec, Š. Grosek   +8 more
semanticscholar   +1 more source

Co-relation of body mass index, dental caries and periodontal status with fluorosis in different high fluoridated areas of Haryana state, India

Indian Journal of Dental Research, 2014
Background and Aim: The aim of the present study is to compare the effect of corticotomy versus prostaglandin E1 injection in human subjects on rate of tooth movement, anchorage loss and their effect on crest bone height and root length.
Manisha Vijayran, Naveen Manuja, Seema Chaudhary, Ashish Sinha, T R Chaitra   +4 more
doaj   +1 more source

Lipo prostaglandin E1

Drug Delivery System, 2009
プロスタグランジンE1（PGE1）は，強力な血小板凝集抑制能，血管拡張能を持つ局所ホルモンである．平均粒径200～300 nm（ナノメートル）のo/wエマルションであるリピッドマイクロスフェアに封入した“リポPGE1”は，障害血管部位，炎症部位などの病変部位へ薬剤を効率よく送り込む“ターゲティング”効果のために，少量で効果を発揮し，副作用の低減を可能とする画期的なDDS製剤となった．リポPGE1は1988年の臨床適用以来，日本だけでなく中国・韓国を含めて，末梢動脈閉塞症をはじめ，循環障害に起因する種々症状の改善・治癒に多大な貢献をしている．
Mitsuko Takenaga, Rie Igarashi
openaire   +2 more sources